-
1
-
-
0011747059
-
Discovery of a novel non peptide antiplatelet GPIIb/IIIa receptor antagonist, DMP 754: Receptor binding afffinity and specificity
-
Mousa, S. A.; Bozarth, J.; Forsythe, M.; Xue, C. B.; Wityak, J.; Olson, R.; Thoolen M. J.; Reilly, T. M. Discovery of a Novel Non Peptide Antiplatelet GPIIb/IIIa Receptor Antagonist, DMP 754: Receptor Binding Afffinity and Specificity. Circulation 1996, 94(8), I-513.
-
(1996)
Circulation
, vol.94
, Issue.8
-
-
Mousa, S.A.1
Bozarth, J.2
Forsythe, M.3
Xue, C.B.4
Wityak, J.5
Olson, R.6
Thoolen, M.J.7
Reilly, T.M.8
-
2
-
-
0004628259
-
Oral antiplatelet effects of DMP 754 in dogs and nonhuman primates
-
Racanelli, A. L.; Kapil, R. P.; Mousa, S. A.; Reilly T. M.; Thoolen, M. J. Oral Antiplatelet Effects of DMP 754 in Dogs and Nonhuman Primates. Circulation 1996, 94(8), I-98.
-
(1996)
Circulation
, vol.94
, Issue.8
-
-
Racanelli, A.L.1
Kapil, R.P.2
Mousa, S.A.3
Reilly, T.M.4
Thoolen, M.J.5
-
3
-
-
85030354989
-
Effect of different acids on solid state stability of an ester prodrug of a glycoprotein IIb/IIIa receptor antagonist
-
Accepted for publication in press
-
Badawy, S. I. F.; Williams, R. C.; Gilbert, D. L. Effect of Different Acids on Solid State Stability of an Ester Prodrug of a Glycoprotein IIb/IIIa Receptor Antagonist. Accepted for publication in Pharm. Dev. Technol., in press.
-
Pharm. Dev. Technol.
-
-
Badawy, S.I.F.1
Williams, R.C.2
Gilbert, D.L.3
-
4
-
-
0025606327
-
The nucleophilicity of dextrose, sucrose, sorbitol and mannitol with p-nitrophenyl esters in aqueous solution
-
Kallion, R. B.; Stella, V. J. The Nucleophilicity of Dextrose, Sucrose, Sorbitol and Mannitol with p-Nitrophenyl Esters in Aqueous Solution. Int. J. Pharm. 1990, 66, 149-155.
-
(1990)
Int. J. Pharm.
, vol.66
, pp. 149-155
-
-
Kallion, R.B.1
Stella, V.J.2
-
5
-
-
0029133921
-
Approaches for improving the stability of ketorolac in powder blends
-
Brandl, M.; Magill, A.; Rudraraju, V.; Gordon, M. S. Approaches for Improving the Stability of Ketorolac in Powder Blends. J. Pharm. Sci. 1995, 84(10), 1151-1153.
-
(1995)
J. Pharm. Sci.
, vol.84
, Issue.10
, pp. 1151-1153
-
-
Brandl, M.1
Magill, A.2
Rudraraju, V.3
Gordon, M.S.4
-
6
-
-
0025024417
-
Drug-excipient incompatibility studies of the dipeptide angiotensin-converting enzyme inhibitor, moexipril hydrochloride: Dry powder vs wet granulation
-
Gu, L.; Strickley, R. G.; Chi L. H.; Chowhan, Z. T. Drug-Excipient Incompatibility Studies of the Dipeptide Angiotensin-Converting Enzyme Inhibitor, Moexipril Hydrochloride: Dry Powder vs Wet Granulation. Pharm. Res. 1990, 7(4), 379-383.
-
(1990)
Pharm. Res.
, vol.7
, Issue.4
, pp. 379-383
-
-
Gu, L.1
Strickley, R.G.2
Chi, L.H.3
Chowhan, Z.T.4
-
7
-
-
0004205176
-
Kinetics and mechanisms of reactions of amidines
-
Patai, S., Ed.; John Wiley & Sons Ltd.: New York
-
De Wolfe, R. H. Kinetics and Mechanisms of Reactions of Amidines. In The Chemistry of Amidines and Imidates; Patai, S., Ed.; John Wiley & Sons Ltd.: New York, 1975; p 354.
-
(1975)
The Chemistry of Amidines and Imidates
, pp. 354
-
-
De Wolfe, R.H.1
-
9
-
-
0344193451
-
Tablet formulation and design
-
Liberman, H. A., Lachman, L., Schwartz, J. B., Eds.; Marcel Dekker Inc.: New York
-
Peck, G. E.; Baley, G. J.; McCurdy, V. E. Tablet Formulation and Design. In Pharmaceutical Dosage Forms: Tablets; Liberman, H. A., Lachman, L., Schwartz, J. B., Eds.; Marcel Dekker Inc.: New York, 1989; Vol. 1, p 111.
-
(1989)
Pharmaceutical Dosage Forms: Tablets
, vol.1
, pp. 111
-
-
Peck, G.E.1
Baley, G.J.2
McCurdy, V.E.3
|